INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Results

76,350 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
KA
Keyes Jason AChief Financial Officer
BLSMBlossomHill Therapeutics, Inc.
Grant or award
A—
56.7K sh
Aug 6, 2026Aug 10, 2026
Page 677 of 1909
← PrevNext →
traded Aug 6, 2026
+4d
SEC Form 4

Evidence

9
RE
Regan Michael EdwardDirector
PFSPROVIDENT FINANCIAL SERVICES INC
Grant or award
A—
3,066 sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

9
CJ
Cui Jingrong JeanDirector, President and CEO, 10% Owner
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
1.60M sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

9
MB
McKinnis Aric BrendanCFO, SVP Global Finance
FORMFORMFACTOR INC
Grant or award
A—
6,924 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
LP
Liptak Vincent PaulGeneral Counsel
BLSMBlossomHill Therapeutics, Inc.
Grant or award
A—
46.6K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
RT
Rottinghaus Scott T.Chief Medical Officer
ENTAENANTA PHARMACEUTICALS INC
Tax withholding
F$20K
1,467 sh
Aug 8, 2026Aug 10, 2026
traded Aug 8, 2026
+2dSEC Form 4

Evidence

9
SJ
Sandison JonathanCFO, Vroom and UACC
VRMVroom, Inc.
Grant or award
A—
30.0K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
CJ
Cui Jingrong JeanDirector, President and CEO, 10% Owner
BLSMBlossomHill Therapeutics, Inc.
Grant or award
A—
676.2K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
OR
Oxnard Geoffrey RaymondChief Medical Officer
BLSMBlossomHill Therapeutics, Inc.
Grant or award
A—
61.8K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
OY
Ofek Amir YechielDirector
GILTGILAT SATELLITE NETWORKS LTD
Option exercise
M—
8,334 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
LT
Lavin Michael T.President
CPSSCONSUMER PORTFOLIO SERVICES, INC.
Option exercise
M—
90.0K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
CJ
Cui Jingrong JeanDirector, President and CEO, 10% Owner
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
124.8K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

9
BM
Behan MarkDirector
AROWARROW FINANCIAL CORP
Option exercise
M—
773 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
MD
Masino Julie D.Director, CEO
CBRLCRACKER BARREL OLD COUNTRY STORE, INC
Tax withholding
F$40K
688 sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

9
SG
Sotiros GeorgeVP - INFORMATION SYSTEMS
WEYSWEYCO GROUP INC
Option exercise
M$22K
780 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
PP
Price Dwayne PChief Accounting Officer
OPLNOPENLANE, Inc.
Option exercise
M—
441 sh
Aug 9, 2026Aug 10, 2026
traded Aug 9, 2026
+1dSEC Form 4

Evidence

9
SG
Sotiros GeorgeVP - INFORMATION SYSTEMS
WEYSWEYCO GROUP INC
Option exercise
M$22K
1,200 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
LY
Li YishanDirector, Executive Chairman, 10% Owner
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
113.4K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

9
DD
Daffey Michael DDirector
GLXYGalaxy Digital Inc.
Grant or award
A—
7,866 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
AS
Agrawal SundeepDirector
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
578.5K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

9
SG
Sotiros GeorgeVP - INFORMATION SYSTEMS
WEYSWEYCO GROUP INC
Option exercise
M$22K
1,200 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
SS
Stellato StevenSee Remarks
KNTKKinetik Holdings Inc.
Grant or award
A—
10.8K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

9
LY
Li YishanDirector, Executive Chairman, 10% Owner
BLSMBlossomHill Therapeutics, Inc.
Grant or award
A—
112.7K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
LY
Li YishanDirector, Executive Chairman, 10% Owner
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
1.60M sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

9
LY
Li YishanDirector, Executive Chairman, 10% Owner
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
1.60M sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

9
AS
Agrawal SundeepDirector
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
578.5K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

9
CG
Combs Michael GCEO & President
CRVLCORVEL CORP
Grant or award
A—
1,500 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

8
SM
Slessor MikeDirector, CEO
FORMFORMFACTOR INC
Tax withholding
F$386K
3,288 sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

7
SS
Sanders A ShaneDirector
CVLTCOMMVAULT SYSTEMS INC
Grant or award · 10b5-1 plan
A—
1,761 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

7
BR
Britt Christopher RDirector, Chief Executive Officer
CHYMChime Financial, Inc.
Derivative conversion · 10b5-1 plan
C—
49.8K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

6
RG
Rosenbaum Michael GeorgeDirector, Chief Executive Officer
GWREGuidewire Software, Inc.
Open-market sale · 10b5-1 plan
SELL$203K
1,200 sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

6
AD
Agarwal DeveshChief Operating Officer
BANDBandwidth Inc.
Option exercise
M—
7,370 sh
Aug 8, 2026Aug 10, 2026
traded Aug 8, 2026
+2dSEC Form 4

Evidence

5
Murdoch Keith RupertChairman Emeritus
FOXFox Corp
Grant or award
A—
35.8K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

5
RD
Rico Robert DanielChief Accounting Officer
GLXYGalaxy Digital Inc.
Option exercise
M—
710 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

5
MA
Modi Rajeev A.SEE REMARKS
ELANElanco Animal Health Inc
Grant or award
A$1,477
67 sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

5
RD
Rico Robert DanielChief Accounting Officer
GLXYGalaxy Digital Inc.
Option exercise
M—
18.8K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

5
LP
Liptak Vincent PaulGeneral Counsel
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
22.7K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

5
RD
Rico Robert DanielChief Accounting Officer
GLXYGalaxy Digital Inc.
Option exercise
M$3,429
710 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

5
LP
Liptak Vincent PaulGeneral Counsel
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
22.7K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

5
QS
Quinton SashaEVP, Pres. CBG
SCHLSCHOLASTIC CORP
Option exercise
M—
22.2K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence